Correlation Between Johnson Johnson and Achilles Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and Achilles Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and Achilles Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and Achilles Therapeutics PLC, you can compare the effects of market volatilities on Johnson Johnson and Achilles Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Achilles Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Achilles Therapeutics.

Diversification Opportunities for Johnson Johnson and Achilles Therapeutics

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Johnson and Achilles is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Achilles Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Achilles Therapeutics PLC and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Achilles Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Achilles Therapeutics PLC has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and Achilles Therapeutics go up and down completely randomly.

Pair Corralation between Johnson Johnson and Achilles Therapeutics

Considering the 90-day investment horizon Johnson Johnson is expected to generate 1.22 times more return on investment than Achilles Therapeutics. However, Johnson Johnson is 1.22 times more volatile than Achilles Therapeutics PLC. It trades about 0.17 of its potential returns per unit of risk. Achilles Therapeutics PLC is currently generating about -0.07 per unit of risk. If you would invest  14,402  in Johnson Johnson on November 2, 2024 and sell it today you would earn a total of  713.00  from holding Johnson Johnson or generate 4.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Johnson Johnson  vs.  Achilles Therapeutics PLC

 Performance 
       Timeline  
Johnson Johnson 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Johnson Johnson has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively steady basic indicators, Johnson Johnson is not utilizing all of its potentials. The latest stock price chaos, may contribute to medium-term losses for the stakeholders.
Achilles Therapeutics PLC 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Achilles Therapeutics PLC are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical indicators, Achilles Therapeutics may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Johnson Johnson and Achilles Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Johnson Johnson and Achilles Therapeutics

The main advantage of trading using opposite Johnson Johnson and Achilles Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, Achilles Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Achilles Therapeutics will offset losses from the drop in Achilles Therapeutics' long position.
The idea behind Johnson Johnson and Achilles Therapeutics PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments